COGNO Ltd is a not-for-profit organisation operating as a charity.
Our purpose is to advance health, particularly in relation to patients and those affected by brain tumours, a rare cancer making up approximately 2% of the Australian adult cancer burden.
We will do this by:
(a) promoting the use of clinical trials in evaluating current therapies, new treatments and supportive interventions for brain tumours and to improve the impact of new clinical trials on future clinical practice;
(b) engaging members of the medical/scientific community to assist in the conduct, evaluation, promotion and development of clinical trials in brain tumours;
(c) promoting the incorporation of translational studies into new clinical trials in brain tumours; and
(d) freely publishing the results of research and clinical trials to increase accessibility and availability to all interested and affected bodies.